{"adverse_reactions":["ADVERSE REACTIONS: Reports of irritation and hypersensitivity to sulfacetamide sodium are uncommon. The following adverse reactions, reported after administration of sterile ophthalmic sulfacetamide sodium, are noteworthy: instances of Stevens-Johnson syndrome and instances of local hypersensitivity which progressed to a syndrome resembling systemic lupus erythematosus; in one case a fatal outcome was reported (see WARNINGS )."],"carcinogenesis_and_mutagenesis_and_impairment_of_fertility":["Carcinogenesis, Mutagenesis and Impairment of Fertility: Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed. Chromosomal nondisjunction has been reported in the yeast, Saccharomyces cerevisiae, following application of sulfacetamide sodium. The significance of this finding to the topical use of sulfacetamide sodium in the human is unknown."],"clinical_pharmacology":["CLINICAL PHARMACOLOGY: Sulfacetamide sodium exerts a bacteriostatic effect against sulfonamide sensitive Gram-positive and Gram-negative microorganisms commonly isolated from secondary cutaneous pyogenic infections. It acts by restricting the synthesis of folic acid required by bacteria for growth, by its competition with para-aminobenzoic acid. There is no clinical data available on the degree and rate of systemic absorption of this product when applied to the skin or scalp. However, significant absorption of sulfacetamide sodium through the skin has been reported. The following in vitro data is available but the clinical significance is unknown. Organisms that show susceptibility to sulfacetamide sodium are: Streptococci, Staphylococci, E. coli, Klebsiella pneumoniae, Pseudomonas pyocyanea, Salmonella species, Proteus vulgaris, Nocardia and Actinomyces. The exact mode of action of sulfur in the treatment of acne is unknown, but it has been reported that it inhibits the growth of Propionibacterium acnes and the formation of free fatty acids."],"contraindications":["CONTRAINDICATIONS: Sodium Sulfacetamide-Sulfur 10%/2% Cleanser is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product. This product is not to be used by patients with kidney disease."],"description":["DESCRIPTION: Each gram of Sodium Sulfacetamide-Sulfur 10%/2% Cleanser contains 100 mg of sulfacetamide sodium, USP and 20 mg of precipitated sulfur, USP in a vehicle consisting of: aloe vera leaf extract, butylated hydroxytoluene, camellia oleifera leaf extract, cetyl alcohol, disodium oleamido MEA-sulfosuccinate, edetate disodium, fragrance, glycerin, glyceryl monostearate, magnesium aluminum silicate, methylparaben, PEG-100 stearate, propylparaben, purified water, sodium cocoyl isethionate, sodium methyl cocoyl taurate, sodium thiosulfate, stearyl alcohol, and xanthan gum. Sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Sulfacetamide sodium, USP is C8H9N2NaO3S·H2O with molecular weight of 254.24. Chemically, sulfacetamide sodium, USP is N-[(4-aminophenyl) sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is: Sulfacetamide sodium, USP is an odorless, white, crystalline powder with a bitter taste. It is freely soluble in water, sparingly soluble in alcohol, while practically insoluble in benzene, in chloroform and in ether. The structural formula of Sulfacetamide."],"dosage_and_administration":["DOSAGE AND ADMINISTRATION: Wash affected areas once or twice daily, or as directed by your physician. Avoid contact with eyes or mucous membranes. Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10 to 20 seconds, working into a full lather, rinse thoroughly and pat dry. If skin dryness occurs, it may be controlled by rinsing product off sooner or using less frequently."],"drug_interactions":["Drug Interactions: This product is incompatible with silver preparations."],"effective_time":"20150201","general_precautions":["General: Nonsusceptible organisms, including fungi, may proliferate with the use of this preparation. Although rare, sensitivity to sulfacetamide sodium may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. If the use of this product produces signs of hypersensitivity or other untoward reactions, discontinue use of the preparation. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved. Systemic absorption of topical sulfonamides is greater following application to large, infected, abraded, denuded or severely burned areas. Under these circumstances, any of the adverse effects produced by the systemic administration of these agents could potentially occur, and appropriate observations and laboratory determinations should be performed. The object of this therapy is to achieve desquamation without irritation, but sulfacetamide sodium and sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility."],"how_supplied":["HOW SUPPLIED: Sodium Sulfacetamide-Sulfur 10%/2% Cleanser is supplied in an 8oz. (227 g) bottle, NDC 58657-475-08. Manufactured for: Method Pharmaceuticals, LLC Arlington, TX 76006 www.methodpharm.com Rev. 09/14"],"id":"056e4d2b-fd20-4086-82a3-4d765cc0373b","indications_and_usage":["INDICATIONS: Sodium Sulfacetamide-Sulfur 10%/2% Cleanser is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis."],"information_for_patients":["Information for Patients: Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or elsewhere. The use of this product also should be discontinued promptly and the physician notified if any arthritis, fever or sores in the mouth develop. Avoid contact with eyes, lips and mucous membranes."],"nursing_mothers":["Nursing mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman. Pediatric use: Safety and effectiveness in children under the age of 12 years have not been established."],"openfda":{},"overdosage":["OVERDOSAGE : The oral LD50 of sulfacetamide in mice is 16.5 g/kg. In the event of overdosage, emergency treatment should be started immediately. Manifestations: Overdosage may cause nausea and vomiting. Large oral overdosage may cause hematuria, crystalluria and renal shutdown due to the precipitation of sulfa crystals in the renal tubules and the urinary tract. For treatment, contact your local Poison Control Center or your doctor immediately. Although rare, sulfacetamide sodium may cause local irritation. Call your doctor for medical advice about side effects. To report SUSPECTED ADVERSE REACTIONS, contact Method Pharmaceuticals, LLC at (877) 250-3427."],"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL NDC 58657-475 -08 Rx Only SODIU M SULFACETAMIDE AND SULFUR 10%/2 % Cleanser For external use only Not for ophthalmic use Net Wt. 8 oz (227 g) PRINCIPAL DISPLAY PANEL NDC 58657-475-08 Rx Only SODIUM SULFACETAMIDE AND SULFUR 10%/2% Cleanser For external use only Not for ophthalmic use Net Wt. 8 oz (227 g)"],"precautions":["PRECAUTIONS: FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE. General: Nonsusceptible organisms, including fungi, may proliferate with the use of this preparation. Although rare, sensitivity to sulfacetamide sodium may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. If the use of this product produces signs of hypersensitivity or other untoward reactions, discontinue use of the preparation. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved. Systemic absorption of topical sulfonamides is greater following application to large, infected, abraded, denuded or severely burned areas. Under these circumstances, any of the adverse effects produced by the systemic administration of these agents could potentially occur, and appropriate observations and laboratory determinations should be performed. The object of this therapy is to achieve desquamation without irritation, but sulfacetamide sodium and sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility. Information for Patients: Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or elsewhere. The use of this product also should be discontinued promptly and the physician notified if any arthritis, fever or sores in the mouth develop. Avoid contact with eyes, lips and mucous membranes. Drug Interactions: This product is incompatible with silver preparations. Carcinogenesis, Mutagenesis and Impairment of Fertility: Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed. Chromosomal nondisjunction has been reported in the yeast, Saccharomyces cerevisiae, following application of sulfacetamide sodium. The significance of this finding to the topical use of sulfacetamide sodium in the human is unknown. Pregnancy: Category C. Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus. Nursing mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman. Pediatric use: Safety and effectiveness in children under the age of 12 years have not been established."],"pregnancy":["Pregnancy: Category C. Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus."],"set_id":"671f7223-ab52-4c20-ac60-e006975dfdfa","spl_product_data_elements":["Sodium Sulfacetamide and Sulfur 10 Percent and 2 Percent Cleanser Sulfacetamide Sodium and Sulfur SULFACETAMIDE SODIUM SULFACETAMIDE SULFUR SULFUR ALOE VERA LEAF BUTYLATED HYDROXYTOLUENE CAMELLIA OLEIFERA LEAF CETYL ALCOHOL DISODIUM OLEAMIDO MONOETHANOLAMINE SULFOSUCCINATE EDETATE DISODIUM GLYCERIN GLYCERYL MONOSTEARATE MAGNESIUM ALUMINUM SILICATE METHYLPARABEN PEG-100 STEARATE PROPYLPARABEN WATER SODIUM COCOYL ISETHIONATE SODIUM METHYL COCOYL TAURATE SODIUM THIOSULFATE STEARYL ALCOHOL XANTHAN GUM"],"spl_unclassified_section":["NDC 58657-475-08 Rx Only Sodium Sulfacetamide And SULFUR 10%/2% Cleanser For external use only Not for ophthalmic use Net Wt. 8 oz (227 g) Method Pharmaceuticals"],"storage_and_handling":["STORAGE: Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). NOTICE: Protect from freezing and excessive heat. The product may tend to darken slightly on storage. Slight discoloration does not impair the efficacy or safety of the product. Keep bottle tightly closed. Occasionally, a slight discoloration of fabric may occur when an excessive amount of the product is used and comes in contact with white fabrics. This discoloration, however, presents no problem, as it is readily removed by ordinary laundering without bleaches."],"version":"2","warnings":["WARNINGS: Sulfonamides are known to cause Stevens-Johnson syndrome in hypersensitive individuals. Stevens-Johnson syndrome also has been reported following the use of sulfacetamide sodium topically. Cases of drug-induced systemic lupus erythematosus from topical sulfacetamide also have been reported. In one of these cases, there was a fatal outcome. KEEP OUT OF REACH OF CHILDREN."]}